CIO Abstract: Transarterial Chemoembolization ± (Tremelimumab and Durvalumab ± Lenvatinib) in Hepatocellular Carcinoma: EMERALD-3

Sunday, September 25, 2022

10:41 AM – 10:49 AM

Location: Americana 3

Speaker(s)